Ectopic Pregnancy
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
OB/GYN EMERGENCIES Elyse Watkins, Dhsc, PA-C, DFAAPA DISCLOSURES
OB/GYN EMERGENCIES Elyse Watkins, DHSc, PA-C, DFAAPA DISCLOSURES I have no financial relationships to disclose. TOPICS Ovarian torsion Postpartum hemorrhage Ruptured ectopic Acute uterine inversion pregnancy Amniotic fluid embolism Acute menorrhagia Placental abruption OVARIAN TORSION OVARIAN TORSION .Tumors (benign and malignant) are implicated in 50-60% of cases of torsion .20% occur during pregnancy (corpus luteum cyst) .Unilateral or bilateral abdominal-pelvic pain, usually sudden onset .Exercise or movement exacerbates pain .Nausea and vomiting 70% .Pathophys: reduced venous return, stromal edema, internal hemorrhage, and infarction → necrosis OVARIAN TORSION .Physical exam variable .Ultrasonography with color Doppler .Surgical referral RUPTURED ECTOPIC PREGNANCY RUPTURED ECTOPIC PREGNANCY .All patients of reproductive age with a hx of missed menses and pelvic pain should be considered to have an ectopic pregnancy until proven otherwise. .A patient with missed menses, irregular vaginal bleeding, pelvic pain, syncope, abdominal pain, and/or dizziness should be managed as a ruptured ectopic pregnancy until proven otherwise. RUPTURED ECTOPIC PREGNANCY .Physical exam of pts with a ruptured ectopic can reveal pelvic tenderness, an adnexal mass, and evidence of hemodynamic compromise. .A transvaginal ultrasound will often show an adnexal mass and/or fluid in the pouch of Douglas. .The serum qualitative βHCG will be > 5 mIu/mL. RUPTURED ECTOPIC PREGNANCY HTTPS://YOUTU.BE/TNN1FPWHOXS RUPTURED ECTOPIC PREGNANCY .Immediately order an H/H, type and cross, and place large bore IV access for fluid support. .Laparotomy is performed when patients are hemodynamically unstable or if visualization during laparoscopy was difficult. .Patients with a ruptured ectopic pregnancy must be managed emergently and surgically! ACUTE MENORRHAGIA ACUTE MENORRHAGIA .Abnormal uterine bleeding (AUB) can result in acute blood loss that causes hemodynamic compromise so prompt evaluation of vital signs is important. -
Olivar C Castejon S. the Histomorphology of Tiny Lobes from the Bilobed Placenta
Cell & Cellular Life Sciences Journal MEDWIN PUBLISHERS ISSN: 2578-4811 Committed to Create Value for researchers The Histomorphology of Tiny Lobes from the Bilobed Placenta Olivar C Castejon S* Research Article Faculty of Health Sciences, University of Carabobo, Venezuela Volume 5 Issue 1 Received Date: January 24, 2020 *Corresponding author: Olivar C Castejon Moc, Faculty of Health Sciences, Laboratory of Published Date: February 14, 2020 Electron Microscopy, Center for Research and Teaching Analysis of the Aragua Nucleus, CIADANA, DOI: 10.23880/cclsj-16000149 Aragua State, Maracay, Venezuela, Email: [email protected] Abstract Two bilobed placentas were obtained of woman pregnancy at 37 and 38 weeks of gestation with newborns live and examined the villous tree with light microscope. Two small lobes were found in one placenta and other in the second placenta. Two normal placentas were taken as control. Ten histological samples by each lobe were processed with H&E stain. Five biopsies by each normal placenta were taken and three histological slides by biopsy were dyed equally. Degenerative changes at level of vessels of the placental villi were noted in stem villi: stromal lysis, multiple capillarity, congestioned vessels, and increased villi, in immature villi the vessels are near to the syncytium indicating extensive hypoxic villous damage. In this condition a dilatation of vessels. Regions of immature villi, pre- infarcts, deficiency of terminal villi in mature intermediate villi, destroyed diminution of the blood flow or events of thrombosis could to be affecting the growth of these small lobules. Keywords: Tiny Placental Lobes; Degenerative Changes; Bipartite Placenta Abbreviations: VEGF: Vascular Endothelial Growth The origen of the bilobed placenta is unknown. -
Ectopic Pregnancy
Ectopic Pregnancy P atient Information Women’s Health Service What is an Ectopic Pregnancy? Symptoms include one or more of the following; An ectopic pregnancy is where the fertilised egg Pain on one side of the lower abdomen. It implants outside the uterus (womb), most may develop sharply, or may slowly get commonly in the fallopian tube (the tube that worse over several days. It can become connects the ovary to the uterus). severe. Vaginal bleeding often occurs, but not Rarely an ectopic pregnancy can occur in the ovary, always. It is often different to the bleeding cervix or abdominal cavity. It usually occurs in the of a period. For example, the bleeding may first ten weeks of pregnancy. be heavier or lighter than a normal period. About 1 in 100 pregnancies in is ectopic. This figure The blood may look darker. However, you rises to 5 in 100 after assisted conception therapies may think the bleeding is a late period. and to 20-30 in 100 after tubal damage due to Other symptoms may occur such as infection or tubal surgery. diarrhoea, feeling faint, or pain on passing faeces (stools). What are the possible causes of an ectopic Shoulder-tip pain may develop. This is due pregnancy? to some blood leaking into the abdomen The chances of having an ectopic pregnancy can be and irritating the diaphragm (the muscle increased by the following: used to breathe). Tubal damage from pelvic infection, If the fallopian tube ruptures and causes endometriosis or appendicitis internal bleeding, you may develop severe Women who have had previous abdominal pain or ‘collapse’. -
Controversies and Complications in Pelvic Reconstructive Surgery (Didactic)
Controversies and Complications in Pelvic Reconstructive Surgery (Didactic) PROGRAM CHAIR Andrew I. Sokol, MD Cheryl B. Iglesia, MD Charles R. Rardin, MD Sponsored by AAGL Advancing Minimally Invasive Gynecology Worldwide Professional Education Information Target Audience Educational activities are developed to meet the needs of surgical gynecologists in practice and in training, as well as, other allied healthcare professionals in the field of gynecology. Accreditation AAGL is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AAGL designates this live activity for a maximum of 3.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. DISCLOSURE OF RELEVANT FINANCIAL RELATIONSHIPS As a provider accredited by the Accreditation Council for Continuing Medical Education, AAGL must ensure balance, independence, and objectivity in all CME activities to promote improvements in health care and not proprietary interests of a commercial interest. The provider controls all decisions related to identification of CME needs, determination of educational objectives, selection and presentation of content, selection of all persons and organizations that will be in a position to control the content, selection of educational methods, and evaluation of the activity. Course chairs, planning committee members, presenters, authors, moderators, panel members, and others in a position to control the content of this activity are required to disclose relevant financial relationships with commercial interests related to the subject matter of this educational activity. Learners are able to assess the potential for commercial bias in information when complete disclosure, resolution of conflicts of interest, and acknowledgment of commercial support are provided prior to the activity. -
Full-Term Abdominal Extrauterine Pregnancy
Masukume et al. Journal of Medical Case Reports 2013, 7:10 JOURNAL OF MEDICAL http://www.jmedicalcasereports.com/content/7/1/10 CASE REPORTS CASE REPORT Open Access Full-term abdominal extrauterine pregnancy complicated by post-operative ascites with successful outcome: a case report Gwinyai Masukume1*, Elton Sengurayi1, Alfred Muchara1, Emmanuel Mucheni2, Wedu Ndebele3 and Solwayo Ngwenya1 Abstract Introduction: Advanced abdominal (extrauterine) pregnancy is a rare condition with high maternal and fetal morbidity and mortality. Because the placentation in advanced abdominal pregnancy is presumed to be inadequate, advanced abdominal pregnancy can be complicated by pre-eclampsia, which is another condition with high maternal and perinatal morbidity and mortality. Diagnosis and management of advanced abdominal pregnancy is difficult. Case presentation: We present the case of a 33-year-old African woman in her first pregnancy who had a full-term advanced abdominal pregnancy and developed gross ascites post-operatively. The patient was successfully managed; both the patient and her baby are apparently doing well. Conclusion: Because most diagnoses of advanced abdominal pregnancy are missed pre-operatively, even with the use of sonography, the cornerstones of successful management seem to be quick intra-operative recognition, surgical skill, ready access to blood products, meticulous post-operative care and thorough assessment of the newborn. Introduction Ovarian, tubal and intraligamentary pregnancies are Advanced abdominal (extrauterine) pregnancy (AAP) is excluded from the definition of AAP. defined as a fetus living or showing signs of having once Maternal and fetal morbidity and mortality are high lived and developed in the mother’s abdominal cavity with AAP [1-5]. -
Gender Reassignment Surgery Policy Number: PG0311 ADVANTAGE | ELITE | HMO Last Review: 07/01/2021
Gender Reassignment Surgery Policy Number: PG0311 ADVANTAGE | ELITE | HMO Last Review: 07/01/2021 INDIVIDUAL MARKETPLACE | PROMEDICA MEDICARE PLAN | PPO GUIDELINES This policy does not certify benefits or authorization of benefits, which is designated by each individual policyholder terms, conditions, exclusions and limitations contract. It does not constitute a contract or guarantee regarding coverage or reimbursement/payment. Self-Insured group specific policy will supersede this general policy when group supplementary plan document or individual plan decision directs otherwise. Paramount applies coding edits to all medical claims through coding logic software to evaluate the accuracy and adherence to accepted national standards. This medical policy is solely for guiding medical necessity and explaining correct procedure reporting used to assist in making coverage decisions and administering benefits. SCOPE X Professional X Facility DESCRIPTION Transgender is a broad term that can be used to describe people whose gender identity is different from the gender they were thought to be when they were born. Gender dysphoria (GD) or gender identity disorder is defined as evidence of a strong and persistent cross-gender identification, which is the desire to be, or the insistence that one is of the other gender. Persons with this disorder experience a sense of discomfort and inappropriateness regarding their anatomic or genetic sexual characteristics. Individuals with GD have persistent feelings of gender discomfort and inappropriateness of their anatomical sex, strong and ongoing cross-gender identification, and a desire to live and be accepted as a member of the opposite sex. Gender Dysphoria (GD) is defined by the Diagnostic and Statistical Manual of Mental Disorders - Fifth Edition, DSM-5™ as a condition characterized by the "distress that may accompany the incongruence between one’s experienced or expressed gender and one’s assigned gender" also known as “natal gender”, which is the individual’s sex determined at birth. -
Oophorectomy Or Salpingectomy— Which Makes More Sense?
Oophorectomy or salpingectomy— which makes more sense? During hysterectomy for benign indications, many surgeons routinely remove the ovaries to prevent cancer. Here’s what we know about this practice. William H. Parker, MD CASE Patient opts for hysterectomy, asks than age 45 to prevent the subsequent devel- about oophorectomy opment of ovarian cancer (FIGURES 1 and 2). Your 46-year-old patient reports increasingly The 2002 Women’s Health Initiative re- severe dysmenorrhea at her annual visit, and a port suggested that exogenous hormone use pelvic examination reveals an enlarged uterus. was associated with a slight increase in the You order pelvic magnetic resonance imaging, risk of breast cancer.2 After its publication, which shows extensive adenomyosis. the rate of oophorectomy at the time of hys- After you counsel the patient about terectomy declined slightly, likely reflect- IN THIS her options, she elects to undergo lapa- ARTICLE ing women’s desire to preserve their own roscopic supracervical hysterectomy and source of estrogen.3 For women younger Algorithm: Should asks whether she should have her ovaries than age 50, further slight declines in the rate the ovaries removed at the time of surgery. She has no of oophorectomy were seen from 2002 to be removed? family history of ovarian or breast cancer. 2010. However, in the United States, almost page 54 What would you recommend for this 300,000 women still undergo “prophylactic” woman, based on her situation and current bilateral salpingo-oophorectomy every year.4 medical research? The lifetime risk of ovarian cancer Ovarian cancer does among women with a BRCA 1 mutation not come from the prophylactic procedure should be is 36% to 46%, and it is 10% to 27% among ovary considered only if 1) there is a rea- women with a BRCA 2 mutation. -
Salpingectomy for Ovarian Cancer Prevention Approved 11/9/2017
Health Evidence Review Commission (HERC) Coverage Guidance: Opportunistic Salpingectomy for Ovarian Cancer Prevention Approved 11/9/2017 HERC Coverage Guidance Opportunistic salpingectomy during gynecological procedures is recommended for coverage, without an increased payment (i.e., using a form of reference-based pricing) (weak recommendation). Note: Definitions for strength of recommendation are in Appendix A. GRADE Informed Framework Element Description. Table of Contents HERC Coverage Guidance ............................................................................................................................. 1 Rationale for development of coverage guidances and multisector intervention reports .......................... 3 GRADE-Informed Framework ....................................................................................................................... 4 Should opportunistic salpingectomy be recommended for coverage for ovarian cancer risk reduction? .................................................................................................................................................................. 4 Clinical Background ....................................................................................................................................... 7 Indications ................................................................................................................................................. 7 Technology Description ........................................................................................................................... -
A Guide to Obstetrical Coding Production of This Document Is Made Possible by Financial Contributions from Health Canada and Provincial and Territorial Governments
ICD-10-CA | CCI A Guide to Obstetrical Coding Production of this document is made possible by financial contributions from Health Canada and provincial and territorial governments. The views expressed herein do not necessarily represent the views of Health Canada or any provincial or territorial government. Unless otherwise indicated, this product uses data provided by Canada’s provinces and territories. All rights reserved. The contents of this publication may be reproduced unaltered, in whole or in part and by any means, solely for non-commercial purposes, provided that the Canadian Institute for Health Information is properly and fully acknowledged as the copyright owner. Any reproduction or use of this publication or its contents for any commercial purpose requires the prior written authorization of the Canadian Institute for Health Information. Reproduction or use that suggests endorsement by, or affiliation with, the Canadian Institute for Health Information is prohibited. For permission or information, please contact CIHI: Canadian Institute for Health Information 495 Richmond Road, Suite 600 Ottawa, Ontario K2A 4H6 Phone: 613-241-7860 Fax: 613-241-8120 www.cihi.ca [email protected] © 2018 Canadian Institute for Health Information Cette publication est aussi disponible en français sous le titre Guide de codification des données en obstétrique. Table of contents About CIHI ................................................................................................................................. 6 Chapter 1: Introduction .............................................................................................................. -
A Full Term Abdominal Pregnancy with an Isthmic Tubal Implantation of the Placenta
Sib et al. BMC Pregnancy and Childbirth (2018) 18:448 https://doi.org/10.1186/s12884-018-2071-z CASEREPORT Open Access A full term abdominal pregnancy with an isthmic tubal implantation of the placenta Sansan Rodrigue Sib1*, Issa Ouédraogo1, Moussa Sanogo1, Sibraogo Kiemtoré2, Yobi Alexis Sawadogo2, Hyacinthe Zamané2 and Blandine Bonané2 Abstract Background: Abdominal pregnancy is defined as the partial or total insertion of the embryo into the abdominal cavity. It is rare, and can evolve towards the full term if it is not recognized in the early pregnancy. It carries a high risk of maternal-fetal morbidity and mortality. Case presentation: We report a case of a 22 year-old gravida IV, para II with an asymptomatic and undiagnosed abdominal pregnancy presumed full term, in a context of health centers under-equipment. She had attended 5 routine antenatal care, but had not performed any ultrasound scan. She had been transferred from a medical center to the Hospital of Ouahigouya (Burkina Faso) for bowel sub-obstruction and intrauterine fetal death, with failure of labor induction. On admission, the hypothesis of uterine rupture or abdominal pregnancy with antepartum fetal demise was considered. A laparotomy was then performed, where an abdominal pregnancy was discovered, and a dead term baby weighing 3300 g delivered. The placenta which was implanted into the ruptured isthmus of the left fallopian tube was removed by salpingectomy. Postoperative follow-up was uneventful. Conclusion: This case report exposes the necessity for the practitioner to think about the possibility of abdominal pregnancy in his clinical and sonographic practice, irrespective of the gestational age, mainly in contexts where there is under-equipment of the health centers. -
New Zealand Data Sheet
NEW ZEALAND DATA SHEET 1. PRODUCT NAME NORIDAY® 28 DAY 0.35 mg tablets .2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains 0.35 mg of norethisterone. Excipients with known effect • Lactose monohydrate For the full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Tablet White, round, flat with bevelled edges, 7/32” diameter, inscribed “SEARLE” on one side and “NY” on the other. 4. CLINICAL PARTICULARS 4.1 Therapeutic indications For oral contraception in women for whom estrogens may not be appropriate. 4.2 Dose and method of administration To achieve maximum contraceptive effectiveness, NORIDAY 28 DAY must be taken exactly as directed. One tablet is taken every day at the same time, with no interruption, whether bleeding occurs or not. Each subsequent pack is started on the day after the previous pack is finished. Contraceptive efficacy may be reduced if a tablet is taken more than 3 hours late. To provide added protection during the first cycle only, the patient should be instructed to use an additional method of contraception (with the exception of rhythm, temperature and cervical- mucus methods). How to start NORIDAY 28 DAY No preceding hormonal contraceptive use (in the past month) Tablet-taking should start on the FIRST DAY of menstrual bleeding. If starting on another day, a non-hormonal back-up method of birth control (such as condoms and spermicide) should be used for the first 48 hours. Thereafter, one tablet is taken continuously at the same time every day preferably in the early evening even during menstrual bleeding. Version: pfdnorit10118 Supercedes: pfdnorit10705 Page 1 of 12 Changing from another type of progestin-only method (implant, injection) Tablet-taking should start on the day of an implant removal or, if using an injection, the day the next injection would be due. -
(8Th Edition) Procedure Code ACHI (8
Appendix 1. Procedure and Diagnostic Codes Used to Identify Prior Procedures Procedure ACHI (8th ACHI (8th edition) procedure names ICD-10- ICD-10-AM edition) AM diagnosis name procedure diagnosis code code Gynecological laparoscopy 35638-00 Laparoscopic wedge resection of ovary 35638-01 Laparoscopic partial oophorectomy 35638-02 Laparoscopic oophorectomy, unilateral 35638-03 Laparoscopic oophorectomy,bilateral 35638-04 Laparoscopic ovarian cystectomy, unilateral 35638-05 Laparoscopic ovarian cystectomy, bilateral 35638-06 Laparoscopic salpingotomy 35638-07 Laparoscopic partial salpingectomy, unilateral 35638-08 Laparoscopic partial salpingectomy, bilateral 35638-09 Laparoscopic salpingectomy, unilateral 35638-10 Laparoscopic salpingectomy, bilateral 35638-11 Laparoscopic salpingo-oophorectomy, unilateral 35638-12 Laparoscopic salpingo-oophorectomy, bilateral 35638-14 Laparoscopic uterosacral nerve ablation 35637-02 Laparoscopic diathermy of lesion of pelvic cavity 35637-04 Laparoscopic ventrosuspension 35637-07 Laparoscopic rupture of ovarian cyst or abscess 35637-08 Laparoscopic ovarian drilling 35637-10 Laparoscopic excision of lesion of pelvic cavity 35729-00 Laparoscopic transposition of ovary 90430-00 Laparoscopic repair of ovary 90433-00 Other laparoscopic repair of fallopian tube 35694-00 Laparoscopic salpingoplasty 35694-01 Laparoscopic anastomosis of fallopian tube 35694-02 Laparoscopic salpingolysis 35694-03 Laparoscopic salpingostomy 35694-06 Laparoscopic salpingotomy 35649-01* Myomectomy of uterus via laparoscopy Hysteroscopy, including operative hysteroscopy 35630-00 Diagnostic hysteroscopy 35649-00 Hysterotomy 35633-00 Division of uterine adhesions 35634-00 Division of uterine septum via hysteroscopy 35649-02 Division of uterine septum via hysterotomy 35633-01 Polypectomy of uterus via hysteroscopy 35623-00 Myomectomy of uterus via hysteroscopy Baldwin HJ, Patterson JA, Nippita TA, Torvaldsen S, Ibiebele I, Simpson JM, et al. Antecedents of abnormally invasive placenta in primiparous women: the risk from gynecologic procedures.